Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube<sup>®</sup>: a randomized clinical trial.

Gomes, Paul J; Abelson, Mark B; Stein, Linda; Viirre, Erik; Villafranca, J Ernest; Lasser, Elliott C

Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube^®: a randomized clinical trial.

Gomes, Paul J; Abelson, Mark B; Stein, Linda; Viirre, Erik; Villafranca, J Ernest; Lasser, Elliott C.

Afiliación

Gomes PJ; Allergy Department, Ora, Inc., Andover, MA, USA, pgomes@oraclinical.com.
Abelson MB; Allergy Department, Ora, Inc., Andover, MA, USA, pgomes@oraclinical.com.
Stein L; Department of Ophthalmology, Harvard Medical School, Cambridge, MA, USA.
Viirre E; Allergy Department, Ora, Inc., Andover, MA, USA, pgomes@oraclinical.com.
Villafranca JE; 3E Therapeutics Corporation, La Jolla, CA, USA.
Lasser EC; 3E Therapeutics Corporation, La Jolla, CA, USA.

J Asthma Allergy ; 12: 71-81, 2019.

Article en En | MEDLINE | ID: mdl-30881050

Palabras clave

allergic rhinitis; allergy; contrast media agent; environmental exposure unit

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Asthma Allergy Año: 2019 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google